{
    "code": "02023508",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023508",
    "time": "2019-11-15 03:18:28",
    "許可證字號": "衛署藥輸字第023508號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/07\/31",
    "發證日期": "91\/07\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202350804",
    "中文品名": "納康點眼液",
    "英文品名": "NAPHCON-A STERILE OPHTHALMIC SOLUTION",
    "適應症": "暫時緩解因輕微眼部刺激所引起之不適或眼睛紅。",
    "劑型": "472點眼液劑",
    "包裝": "100ML以下無菌塑膠滴瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "17醫師藥師藥劑生指示藥",
    "主成分略述": "PHENIRAMINE MALEATE, NAPHAZOLINE HCL",
    "主製造廠": {
        "申請商名稱": "1304601100  瑞士商愛爾康大藥廠股份有限公司台灣分公司",
        "申請商地址": "新北市新店區寶中路119號四樓",
        "主製造廠": "",
        "製造廠名稱": "FBE0037000  S.A. ALCON-COUVREUR N.V."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400003010",
            "成分名稱": "PHENIRAMINE MALEATE",
            "含量描述": "",
            "含量": "3.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212001910",
            "成分名稱": "NAPHAZOLINE HCL",
            "含量描述": "",
            "含量": "0.2500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Naphcon A_20171113-106-11-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023508&Seq=001&Type=9"
        }
    ]
}